| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
293,420,000 |
| Market
Cap: |
31.10(B) |
| Last
Volume: |
1,540,864 |
Avg
Vol: |
2,532,378 |
| 52
Week Range: |
$80.08 - $115.62 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Wholesale |
| Level
III Sector: |
Drugs Wholesale |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 778 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Cardinal Health is a healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. Co. manages its business in two segments: Pharmaceutical and Medical. Co.'s Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the U.S. Co.'s Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the U.S., Canada, Europe, Asia and other markets.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
550 |
| Total Buy Value |
$0 |
$0 |
$0 |
$42,165 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
36,642 |
170,686 |
251,492 |
| Total Sell Value |
$0 |
$3,895,411 |
$15,706,591 |
$22,202,192 |
| Total People Sold |
0 |
1 |
6 |
6 |
| Total Sell Transactions |
0 |
1 |
8 |
10 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Greene Michelle D. |
Chief Information Officer |
• – – |
2024-03-15 |
4 |
D |
$109.93 |
$72,994 |
D/D |
(664) |
19,486 |
|
- |
|
| Azelby Robert |
Director |
– • – |
2024-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,288 |
1,288 |
|
- |
|
| Alt Aaron E |
Chief Financial Officer |
• – – |
2024-02-15 |
4 |
D |
$103.55 |
$198,712 |
D/D |
(1,919) |
27,400 |
|
- |
|
| Greene Michelle D. |
Chief Information Officer |
• – – |
2024-02-15 |
4 |
D |
$103.55 |
$68,757 |
D/D |
(664) |
20,150 |
|
- |
|
| Scherer Mary C. |
Chief Accounting Officer |
• – – |
2023-12-01 |
4 |
D |
$107.08 |
$23,236 |
D/D |
(217) |
10,432 |
|
- |
|
| Weitzman Deborah |
CEO, Pharmaceutical Segment |
• – – |
2023-12-01 |
4 |
D |
$107.08 |
$68,317 |
D/D |
(638) |
34,564 |
|
- |
|
| Snow Ola M |
Chief Human Resources Officer |
• – – |
2023-12-01 |
4 |
D |
$107.08 |
$40,905 |
D/D |
(382) |
24,842 |
|
- |
|
| Weitzman Deborah |
CEO, Pharmaceutical Segment |
• – – |
2023-11-27 |
4 |
AS |
$106.31 |
$3,895,411 |
D/D |
(36,642) |
35,202 |
|
3% |
|
| Weitzman Deborah |
CEO, Pharmaceutical Segment |
• – – |
2023-11-27 |
4 |
OE |
$66.43 |
$2,048,356 |
D/D |
27,642 |
71,844 |
|
- |
|
| Mayer Jessica L |
Chief Legal/Compliance Officer |
• – – |
2023-11-15 |
4 |
D |
$102.90 |
$533,537 |
D/D |
(5,185) |
79,680 |
|
- |
|
| Evans David C |
Director |
– • – |
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,965 |
12,576 |
|
- |
|
| Johri Akhil |
Director |
– • – |
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,965 |
20,071 |
|
- |
|
| Killefer Nancy |
Director |
– • – |
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,965 |
24,827 |
|
- |
|
| Kenny Gregory B |
Director |
– • – |
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,193 |
59,680 |
|
- |
|
| Mundkur Christine |
Director |
– • – |
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,965 |
4,739 |
|
- |
|
| Hall Patricia Hemingway |
Director |
– • – |
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,965 |
29,467 |
|
- |
|
| Chandrasekaran Sujatha |
Director |
– • – |
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,965 |
4,739 |
|
- |
|
| Edison Sheri H. |
Director |
– • – |
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,965 |
12,051 |
|
- |
|
| Brennan Michelle |
Director |
– • – |
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,965 |
5,289 |
|
- |
|
| Barg Steven |
Director |
– • – |
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,965 |
4,739 |
|
- |
|
| Weitzman Deborah |
CEO, Pharmaceutical Segment |
• – – |
2023-08-28 |
4 |
S |
$89.81 |
$602,805 |
D/D |
(6,712) |
44,202 |
|
-18% |
|
| Weitzman Deborah |
CEO, Pharmaceutical Segment |
• – – |
2023-08-28 |
4 |
OE |
$71.43 |
$479,438 |
D/D |
6,712 |
50,914 |
|
- |
|
| Scherer Mary C. |
Chief Accounting Officer |
• – – |
2023-08-18 |
4 |
S |
$86.27 |
$1,785,358 |
D/D |
(20,695) |
10,649 |
|
-18% |
|
| Scherer Mary C. |
Chief Accounting Officer |
• – – |
2023-08-18 |
4 |
OE |
$66.43 |
$863,646 |
D/D |
11,460 |
31,344 |
|
- |
|
| Mayer Jessica L |
Chief Legal/Compliance Officer |
• – – |
2023-08-17 |
4 |
S |
$87.68 |
$935,370 |
D/D |
(10,668) |
84,865 |
|
-17% |
|
570 Records found
|
|
Page 1 of 23 |
|
|
1.17 (1.09%) 
